Replies to post #37516 on Ayala Pharmaceuticals Inc (ADXS)

[terry hallinan]

If I have a choice of partnership vs. dilution

But, Traderbx, any partnership is dilution no matter the current cant.

Thank you for a civil and rational reply.

I have even admitted the ultimate dilution by the sale of all rights to ADXS' crown jewel in development was a coup in my opinion while it depreciated the entire Lm cancer vaccine platform.

AMGN takes on high risk and leaves ADXS with likely hefty license fees if all goes well. Meantime ADXS retains full ownership of a platform with even greater value than the cancer vaccine platform in my estimation.

Best, Terry